The human granulocytic ehrlichiosis (HGE) agent in Swedish ticks  by von Stedingk, Lars Victor et al.
-~ ~~ ~ ~ 
SHORT COMMUNICATIONS and letters to the Editors 
The human granulocytic ehrlichiosis (HGE) agent in 
Swedish ticks 
Clin Microbiol Infect 1997; 3: 573-574 
Hunian ehrlichiosis is an emergent tick-borne infection 
increasingly reported from the USA [l]. 
Antibodies in humans as evidence of the presence 
of granulocytic Ehrlichia infection have recently been 
reported from Switzerland [2], the UK 131 and Norway 
[4] and have been found in Sweden [5]. An Ehrlichia 
strain with identical 16s rDNA nucleotide sequence to 
that of the agent of human granulocytic ehrlichiosis 
(HGE), has been identified as causing disease in 
Swedish dogs and horses [6,7]. 
Presence of the HGE agent in Ixodes scapularis ticks 
has been demonstrated in the US [8] but not in the 
related I .  ricinur ticks of western Europe. We therefore 
used a PCR-based test, which is specific for the HGE 
agent, Ehrlichia equi and E. phagocytophilu [7], to study 
a total of 151 ticks at the nymphal stage, collected on 
the west and east coasts of Sweden. Of  the 151 ticks, 
10 (6.6%) were found to contain ehrlichial DNA. Of  
the 87 ticks from the west coast of Sweden, 8 (9.2%) 
were positive (Table 1). These ticks had been collected 
on the Koster islands, where antibodies to the HGE 
agent had previously been found in serum samples from 
healthy inhabitants [5]. O f  the 64 ticks from the 
Stockholm area on the east coast of Sweden, two (3.1%) 
were found to be positive for Ehrlichiu, and 14.1% for 
B. buydorjeeri sensu lato by PCR. No co-infections with 
Elirlichia and B. buydoferi  sensu lato were found. 
Table 1 Nucleotide differences close to the 5’ end of the 
16s rDNA sequences of E. eqtri, E. phupcyytcyhila, HGE 
agent and Swedish tick ehrlichiae 
Nucleotide difference at position” 
Ehrlichiae (110. of positive 
ticks found) 49 90 98 
E. cqui c A A 
E. phqorytophila T A A 
HGE agent T A G 
Swedish Ehrlichia type I (1) T A G 
Swedish Ehrlichia type I1 (3) T G G 
Swedish Ehrlichia type 111 (6) T G A 
’According to the International Union of Biochemistry numbering 
of the Escherichia coli 16s rDNA sequence. GenBank accession 
numbers: E .  rqui (M73223), E. phagocytophila (M73220), HGE 
agent (U02521). 
hIncluding both positives from the east coast. 
After extraction of frozen and disintegrated ticks, 
the DNA was processed by the QIAamp Tissue kit 
(QIAGEN, Hilden, Germany). The products of the 
16s rDNA-based PCR method, approximately 600 
base-pairs, were sequenced [7]. The ehrlichiae were 
found to be of three types (Table 1): one type identical 
to the HGE agent, three similar to the HGE agent but 
with a G instead of an A at position 90 and six similar 
to E.  phagocytophila but with a G instead of an A at 
position 90. 
Based on 16s rRNA gene sequence analysis of 
previous studies, all Swedish canine and equine 
ehrlichiae have been found to be of the HGE type 
[6,7]. In cattle, E. ylzagocytophila has been demonstrated, 
but also another Ehrlichia strain, which in positions 
close to the 5’ end of the 16s rDNA differed from 
both the HGE agent and from E. phagocytopliila. The 
nucleotide differences found in the positive ticks in the 
present study were also close to the 5’ end (Table 1) but 
in other positions as compared to those of the cattle 
strain. The importance of these sequence differences 
remains to be elucidated. 
This first demonstration of the presence of 
ehrlichiae in ticks in a European country, which is 
endemic for both Lyme borreliosis (LB) and tick-borne 
encephalitis (TBE), indicates that further studies are 
needed to identify human clinical cases of ehrlichiosis 
and of possible co-infections with other tick-borne 
pathogens. A recent study from the USA [9] has shown 
both more severe and more protracted LB infection in 
individuals co-infected with Babesia rnicrofi. I n  Europe, 
B. divergens is known to cause human disease and 
B. rnicvoti has been isolated from rodents [lo]. Co- 
infections with two or several tick-borne agents, of 
which Ehrlichia is known to be immunosuppressive in 
animals, may aggravate the clinical picture of LB and 
TBE also in Europe. 
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Multiple intracranial tuberculomas in a 
non-immunocompromised patient 
Cliiz Microbiol Infect 1997; 3: 574-576 
Tuberculous involvement of the central nervous system 
usually appears as tuberculous meningitis or tuber- 
culoma, which often presents as a single intracranial 
lesion. Multiple intracranial tuberculomas can also be 
encountered. We report a case of 38 intracranial tuber- 
culoinas in a non-immunocompronlised patient. 
A 33-year-old Laotian man, resident in France for 
7 years, was admitted to hospital with a 2-month 
history of headache, anorexia and sleep disturbances. 
Treatment with tricyclic antidepressants and benzo- 
diazepines had been instituted 3 weeks before, with 
no effect. O n  admission the patient was drowsy, un- 
cooperative and unresponsive. His temperature was 
38.6OC. Examination showed a right Babinski sign; 
there was no stiff neck, ataxia or visual disturbance. 
Hematologic and biochemical tests were normal except 
for an erythrocyte sedimentation rate of 66 mm/h and 
an alkaline phosphatase level of 173 U/L. Tuberculin 
test and human immunodeficiency virus serology were 
negative. Chest X-ray showed diffuse reticulonodular 
infiltrates. 
Contrast-enhanced computerized tomography (CT) 
scan of the head revealed multiple solid and ring- 
enhancing lesions, both supra- and infratentorial. At 
lumbar puncture, the cerebrospinal fluid (CSF) was 
clear and contained leukocytes at 53/mm3 (segmented 
cells 45%, lymphocytes 45%) with a protein level 
1.7 g/L, and a glucose level of 0.6 minol/L (blood 
glucose: 5.6 mmol/L); no acid-alcohol-fast bacilli 
(AAFB) were seen. 
AAFB were detected in the sputum. A diagnosis of 
miliary tuberculosis with cerebral tuberculomas was 
made and a four-drug daily regimen was given with 
isoniazid 300 mg, rifampicin 600 mg, pyrazinamide 
2000 mg and ofloxacin 600 mg associated with pred- 
nisolone 60 mg daily. Initial magnetic resonance (MR) 
imaging demonstrated 20 supratentorial and 18 infra- 
tentorial lesions, showing nodular or ring enhancement 
after gadolinium (Figures 1 and 2). Percutaneous biopsy 
of the liver demonstrated granulomatous infiltration. 
After 6 weeks of incubation, sputum cultures grew 
Mycobacterium tuberculosis, which was sensitive to all the 
first-line antituberculous drugs. Cultures from liver and 
CSF were negative for M .  tuberculosis. 
After 2 months of treatment, headaches had re- 
solved but changes in mental status persisted. Cerebral 
MR imaging showed persistence of many lesions. 
Pyrazinamide and ofloxacin were discontinued. Over 
the next 6 months, patient had complete resolution 
of his neurologic signs and miliary shadowing dis- 
appeared from the chest X-ray. Prednisolone was 
gradually discontinued. After 12 months of medical 
management, follow-up MR examination showed 
regression of most tuberculomas, and persistence of 
three periventricular tuberculomas, whose size, how- 
ever, had clearly decreased. 
Diagnosis of intracranial tuberculoma has in the 
past been confirmed either at  surgery or at autopsy [l]. 
Since the advent of CT, a large number of reported 
cases have concerned one, sometimes two or three, 
